Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Aquilina G, Ceccotti S, Martinelli S, Hampson R and Bignami M (1998) N-(2-chloroethyl)-N’-cyclohexyl-N-nitrosourea sensitivity in mismatch repair-defective human cells. Cancer Res 58: 135–141
Barrett P, Seymour MT and Stenning SP et al (2001) Molecular markers predicting benefit from adjuvant 5-fluorouracil in colon cancer patients. (submitted, Lancet)
Dube S, Heyen F and Jenicek M (1997) Adjuvant chemotherapy in colorectal carcinoma: results of a meta-analysis. Diseases of the Colon & Rectum 40, (1):35–41
Elsaleh H, Joseph D, Grieu F, Zeps N, Spry N and Iacopetta B (2000) Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet 355: 1745–1750
Francini G, Petrioli R, Lorenzini L, Mancini S, Armenio S, Tanzini G, Marsili S, Aquino A, Marzocca G and Civitelli S (1994) Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. Gastroenterology 106, (4):899–906
Haller PJ, Catalano JS, Macdonald RJ and Mayer, (1998) Eastern cooperative Oncology Group (ECOG);Southwest Oncology Group (SWOG); Cancer and Leukemia Group B (CALGB) Fluorouracil (FU) leucovorin (LV) and levamisole (LEV) adjuvant therapy for colon cancer: Five year final report of Int-0089 D.G. Proc Am Soc Clin Oncol 17: 256(abstr)
International Multicentre pooled analysis of colon cancer trials (IMPACT) Investigators (1995) Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 345: 939–944
International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators (1999) Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. J Clin Oncol 17: 1356–1363
Jen J, Kim H, Piantadosi S, Liu ZF, Levitt RC, Sistonen P, Kinzler KW, Vogelstein B and Hamilton SR (1994) Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J of Med 331, (4):213–221
Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, Kubista TP, Poon MA, Meyers WC and Mailliard JA (1991) Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324, (11):709–715
Laurie JA, Moertel CG, Fleming TR, Wieand HS, Leigh JE, Rubin J, McCormack GW, Gerstner JB, Krook JE and Mallird J (1989) Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil.The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol 7, (10):1447–1456
Mamounas E, Wieand S, Wolmark N, Bear HD, Atkins JN, Song K, Jones J and Rockette H (1999) Comparative efficacy of adjuvant chemotherapy in patients with Dukes’ B versus Dukes’ C colon cancer: results from four National surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03 and C-04). J Clin Oncol 17, (5):1349–1355
Maughan TS, James RD, Kerr DJ, Ledermann J, McArdle C, Seymour M, Topham C, Cain D and Stephens RJ (2001) Continuous versus Intermittant chemotherapy for advanced colorectal cancer: Preliminary results of an MRC Cro6b randomised trial. Proc Am Soc Clin Oncol 21: 125a
Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen CM, Ungerleider JS, Emerson WA, Tormey DC and Glick JH (1995) Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 122, (5):321–326
NHS Executive (1997) Improving Outcomes in colorectal cancer: the research evidence.
O’Connell MJ, Maillard JA, Kahn MJ, Macdonald JS, Haller DG, Mayer RJ and Wieand HS (1997) Controlled trial of fluorouracil and low-dose leucovorin given for six months as post-operative adjuvant therapy for colon cancer. J Clin Oncol 15, (1):246–250
Quasar collaborative group (2000a) Comparison of fluorouracil with additional levamisole, higher dose folinic acid or both as adjuvant chemotherapy for colorectal cancer: a randomised trial. Lancet 355: 1588–1596
QUASAR colorectal cancer study group (2000b) Adjuvant chemotherapy with 5-fluorouracil, 1-folinic acid and levamisole for patients with colorectal cancer: comparison of weekly versus monthly schedules. Annals of Oncol 11: 947–955
Saini A, Cunningham D, Norman AR, Hill ME, Tait D, Hickish T, Iveson T, Lofts F, Jodrell D, Ross PJ and Oates JR (2000) Multicentre randomised trial of protracted venous infusion(PVI) 5FU compared to 5FU/folinic acid as adjuvant therapy for colorectal cancer. Proc Am Soc Clin Oncol 20: 2410a
Sakamoto J, Hamada C, Kodaira S, Nakazato H and Ohashi Y (1999) Adjuvant therapy with oral fluoropyrimidines as main chemotherapeutic agents after curative resection for colorectal cancer: individual patient data meta-analysis of randomised trials. Jpn J Clin Oncol 29, (2):78–86
Taal BG, van Tinteren H and Zoetmulder FAN on behalf of the NACCP group (2001) Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III. Br J Cancer, xxxxxx
Wolmark N, Rockette H, Mamounas E, Jones J, Wieand S, Wickerham DL, Bear HD, Atkins JN, Dimitrov NV, Glass AG, Fisher ER and Fisher B (1999) Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes’ B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04. J Clin Oncol 17, (11):3553–3559
Wolmark N, Wieand HS, Hyams DM, Colangelo L, Dimitrov NV, Romond EH, Wexler M, Prager D, Cruz AB Jr, Gordon PH, Petrelli NJ, Deusch M, Mamounas E, Wickerham DL, Fisher ER, Rockette H and Fisher B (2000) Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. Journal of the National Cancer Institute 92, (5):388–396
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Maughan, T. Adjuvant chemotherapy for colorectal cancer. Br J Cancer 85, 1422–1424 (2001). https://doi.org/10.1054/bjoc.2001.2081
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.2081
This article is cited by
-
Predictive values of sex and tumour site for survival benefit from 5FU in colorectal cancer
British Journal of Cancer (2002)
-
Adjuvant treatment in colorectal cancer
British Journal of Cancer (2002)